Munich - Delayed Quote EUR
Dermapharm Holding SE (DMP.MU)
37.50
0.00
(0.00%)
At close: April 25 at 8:00:51 AM GMT+2
Loading Chart for DMP.MU
- Previous Close
37.50 - Open
37.50 - Bid 38.20 x --
- Ask 38.70 x --
- Day's Range
37.50 - 37.50 - 52 Week Range
30.50 - 41.80 - Volume
0 - Avg. Volume
4 - Market Cap (intraday)
-- - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date May 15, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Recent News: DMP.MU
View MorePerformance Overview: DMP.MU
Trailing total returns as of 4/25/2025, which may include dividends or other distributions. Benchmark is DAX P (^GDAXI) .
YTD Return
DMP.MU
1.96%
DAX P (^GDAXI)
11.72%
1-Year Return
DMP.MU
21.25%
DAX P (^GDAXI)
24.14%
3-Year Return
DMP.MU
27.65%
DAX P (^GDAXI)
59.74%
5-Year Return
DMP.MU
4.07%
DAX P (^GDAXI)
115.19%
Compare To: DMP.MU
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
37.50
0.00%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
5.31
-2.57%
Mkt Cap EUR 1.288B
Industry Drug Manufacturers—Specialty & Generic
0.0830
+2.03%
Mkt Cap 13.115M
Industry Drug Manufacturers—Specialty & Generic
Statistics: DMP.MU
View MoreValuation Measures
As of 4/25/2025
Market Cap
2.05B
Enterprise Value
2.90B
Trailing P/E
17.77
Forward P/E
15.62
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.71
Price/Book (mrq)
3.34
Enterprise Value/Revenue
2.46
Enterprise Value/EBITDA
9.05
Financial Highlights
Profitability and Income Statement
Profit Margin
--
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
--
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
--
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
--